|
Market Closed -
Bombay S.E.
05:02:29 2026-11-11 am EST
|
5-day change | 1st Jan Change | ||
| 2,726.40 INR | +0.57% |
|
+5.95% | +10.34% |
| Market Cap | 459B 4.9B 4.39B 4.05B 3.68B 6.96B 7.15B 48.47B 19.31B 246B 18.38B 17.99B 778B | P/E 2027 * |
39.1x | P/E 2028 * | 34.2x |
|---|---|---|---|---|---|
| Enterprise Value | 459B 4.9B 4.39B 4.05B 3.68B 6.96B 7.15B 48.47B 19.31B 246B 18.38B 17.99B 778B | EV / Sales 2027 * |
10.6x | EV / Sales 2028 * | 9.47x |
| Free-Float |
24.34% | Yield 2027 * |
1.09% | Yield 2028 * | 1.09% |
| Markets | Quality | ||
|---|---|---|---|
Bombay S.E.
| GLAXO | Delayed | |
NSE India S.E.
| GLAXO | Delayed |
Last Transcript: GlaxoSmithKline Pharmaceuticals Limited
| 1 day | +0.57% | ||
| 1 week | +5.95% | ||
| Current month | +9.78% | ||
| 1 month | +7.35% | ||
| 3 months | +4.82% | ||
| 6 months | +9.73% | ||
| Current year | +10.34% |
| 1 week | 2,494.25 |  | 2,770 |
| 1 month | 2,342.7 | | 2,770 |
| Current year | 2,088 | | 3,121.1 |
| 1 year | 2,088 | | 3,121.1 |
| 3 years | 1,463.2 | | 3,515.95 |
| 5 years | 1,228 | | 3,515.95 |
| 10 years | 1,020 | | 3,515.95 |
| Manager | Title | Age | Since |
|---|---|---|---|
Bhushan Akshikar
CEO | Chief Executive Officer | 56 | 2022-11-30 |
Ronojit Biswas
DFI | Director of Finance/CFO | - | 2026-03-31 |
Vibhuti Gupta
COO | Chief Operating Officer | - | 2024-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Renu Sud Karnad
CHM | Chairman | 73 | 2019-03-31 |
| Director/Board Member | 59 | 2020-05-17 | |
Manu Anand
BRD | Director/Board Member | 67 | 2022-05-15 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.57% | +5.95% | +7.33% | +84.87% | 4.9B | |
| -0.84% | -0.09% | +43.30% | +131.22% | 1,276B | |
| -1.16% | +0.21% | +42.85% | +87.56% | 676B | |
| -1.10% | -1.68% | +28.73% | +109.08% | 519B | |
| -0.36% | +0.88% | +38.34% | +67.29% | 388B | |
| -1.47% | -3.29% | +59.88% | +41.90% | 365B | |
| -1.32% | -1.30% | +27.33% | +56.61% | 307B | |
| -0.07% | -1.32% | +2.77% | +35.04% | 287B | |
| -0.72% | -3.63% | +36.24% | +72.90% | 252B | |
| -0.79% | -2.79% | +38.39% | +126.36% | 212B | |
| Average | -0.74% | +2.83% | +32.52% | +81.28% | 429B | |
| Weighted average by Cap. | -0.90% | +2.52% | +37.87% | +92.76% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 43.34B 462M 414M 382M 347M 657M 675M 4.57B 1.82B 23.22B 1.73B 1.7B 73.4B | 48.47B 517M 464M 427M 388M 734M 755M 5.12B 2.04B 25.97B 1.94B 1.9B 82.09B |
| Net income | 11.85B 126M 113M 104M 94.86M 180M 185M 1.25B 498M 6.35B 474M 464M 20.07B | 13.41B 143M 128M 118M 107M 203M 209M 1.42B 564M 7.18B 537M 525M 22.71B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-11 | ₹2,726.40 | +0.57% | 9,488 |
| 26-11-09 | ₹2,710.85 | +6.77% | 35,096 |
| 26-11-08 | ₹2,538.95 | +0.56% | 2,376 |
| 26-11-06 | ₹2,524.85 | +0.97% | 38,527 |
| 26-11-05 | ₹2,500.70 | -1.26% | 54,969 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GLAXO Stock
Select your edition
All financial news and data tailored to specific country editions
